Fraser Nicola Marion 4
Research Summary
AI-generated summary
Intelligent Bio Solutions (INBS) Director Fraser Marion Receives Award
What Happened
Fraser Nicola Marion, a director of Intelligent Bio Solutions Inc. (INBS), was granted 5,000 restricted shares of common stock on March 18, 2026. The shares were reported at $0.00 per share (total reported value $0) and were granted under the company's 2019 Long Term Incentive Plan. This transaction is an equity award (grant), not an open‑market purchase or sale.
Key Details
- Transaction date: March 18, 2026. Transaction type/code: Award/Grant (A).
- Shares granted: 5,000 restricted shares; reported price: $0.00; reported total value: $0.
- Vesting/forfeiture: Time‑based vesting after 12 months; shares are subject to forfeiture until vested (per filing).
- Reverse split note: All amounts are presented post a 1-for-10 reverse stock split effective Dec 15, 2025 (filing footnote).
- Shares owned after transaction: Not specified in the Form 4 filing.
- Filing timeliness: The Form 4 was filed on Mar 20, 2026 for a Mar 18, 2026 transaction; no late‑filing indication was reported.
Context
Restricted share grants are compensation awards and differ from purchases or sales — they generally reflect company compensation decisions rather than immediate insider buying/selling activity. These shares will not be freely tradable until they vest (12‑month time‑based vesting) and remain subject to forfeiture until that time. The filing shows amounts post-reverse split, so share counts reflect the reduced outstanding share base after the Dec 2025 1-for-10 reverse split.